Skip to main content

Patient Representative: Hilary Horlock

Supportive Care Committee
Resides in Vancouver, BC | CCTG Patient Representative since 2022
“On my own personal cancer journey and listening to the experiences of other patients in the chemo and radiation rooms, it was clear that our lived experiences would be helpful to the researchers and scientists developing trial protocols. Patients can bring so much insight to the development of the trials and treatments, providing firsthand experiences on what happens to our bodies, our mental health and what’s important to us from a quality-of-life perspective.”

Hilary Horlock is a Senior Enterprise Architect. She specializes in healthcare technology design from an end user perspective. Implementing technology successfully in complex health care ecosystems often comprised of large personalities and competing demands takes expert navigation skills, liberal doses of good humor, a keen sense of observation and refreshing honesty.

Passionate about improving the patient experience, this passion gained extra fuel and insight when she learned she had cancer in June of 2015.  For her work to improve the breast cancer patient experience, Hilary was awarded the Health Employers Association of BC (HEABC) 2017 Health Care Hero award. In addition to being a voice for change in the patient journey, she worked with patients and oncology professionals to publish the Patient-friendly Guide to Pathology Reports.

Constantly looking for ways to make things better and endlessly curious, Hilary loves to learn, laugh, Stand Up Paddle, play on a beach, travel far and wide, and eat chocolate - not necessarily in that order.

“As partners in the design of a clinical trial we become part of a team that looks at an outcome holistically, including the viewpoints and priorities of all the stakeholders. Patients benefit from learning more about the science behind the development of a treatment and can become better advocates for research, while the scientists and researchers can learn from patients’ journeys, from the intended and unintended consequences from drug and other therapies.”